SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: S-1/A
Date Filed: 2026-05-15
Accession Number: 0001493152-26-023752
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226023752/forms-1a.htm

Chunk 22 of 94
Word Count: 1455
Character Count: 9495

Document Content:

to comply with our obligations in our intellectual property licenses and other agreements with third parties. we fail to comply with our obligations in our intellectual property licenses and other agreements with third parties, we could lose license rights that are important to our business. We are not currently party to any intellectual property license agreement with any third parties, but we anticipate that in-licensing and co-development will be strategies that we utilize as we continue to pursue our growth strategy. We expect to enter into licenses and co-development and other agreements in the future, and we expect these agreements to impose, various diligences, milestone payment, royalty, insurance and other obligations on us. If we fail to comply with these obligations, the licensor may have the right to terminate the license, in which event we might not be able to market any product that is covered by the licensed patents.

may need to resort to litigation to enforce or defend our intellectual property rights, including any patents issued to us. If a competitor
or collaborator files a patent application claiming technology also invented by us, in order to protect our rights, we may have to participate
in an expensive and time-consuming interference proceeding before the United States Patent and Trademark Office. We cannot guarantee
that our product candidates will be free of claims by third parties alleging that we have infringed their intellectual property rights.
Third parties may assert that we are employing their proprietary technologies without authorization and they may resort to litigation
to attempt to enforce their rights. Third parties may have or obtain patents in the future and claim that the use of our technology or
any of our product candidates infringes their patents. We may not be able to develop or commercialize combination product candidates
because of patent protection others have. Our business will be harmed if we cannot obtain a necessary or desirable license, can obtain
such a license only on terms we consider to be unattractive or unacceptable, or if we are unable to redesign our product candidates or
processes to avoid actual or potential patent or other intellectual property infringement. Obtaining, protecting and defending patent
and other intellectual property rights can be expensive and may require us to incur substantial costs, including the diversion of management
and technical personnel. An unfavorable ruling in patent or intellectual property litigation could subject us to significant liabilities
to third parties, require us to cease developing, manufacturing or selling the affected product candidates or using the affected processes,
require us to license the disputed rights from third parties, or result in awards of substantial damages against us.

There
can be no assurance that we would prevail in any intellectual property infringement action, will be able to obtain a license to any third-party
intellectual property on commercially reasonable terms, successfully develop non-infringing alternatives on a timely basis, or license
non-infringing alternatives, if any exist, on commercially reasonable terms. Any significant intellectual property impediment to our
ability to develop and commercialize our product candidates could seriously harm our business and prospects.

we are unable to adequately protect our proprietary technology or obtain and maintain issued patents that are sufficient to protect our
product candidates, product candidates, and methods others could compete against us more directly, which could harm our business, financial
condition and results of operations.

Our
intellectual property and proprietary rights are important to our ability to remain competitive and for the success of our product candidates
and our business. Patent protection can be limited and not all intellectual property is or can be patented. Our commercial success may
depend in part on our ability to obtain and maintain patents and other intellectual property rights in the United States and elsewhere,
and protect our proprietary technologies. If we do not adequately protect our intellectual property and proprietary technologies, competitors
may be able to use our technologies and erode or negate any competitive advantage we may have, which could harm our business and profitability.

We have filed
patent applications for our product candidates and related intellectual property with the U.S. Patent and Trademark Office and in other
jurisdictions. As of March 31, 2026, we have been granted over one hundred (100) patents including over 50 patents in the United States,
and we have another 9 pending applications in various stages of review.

Our
patents may not have, or our pending patent applications that mature into issued patents may not include, claims with a scope sufficient
to protect our product candidates, product candidates, or methods. Other parties may have developed technologies that may be related
or competitive to our product candidates, product candidates, and methods, may have filed or may file patent applications for those technologies,
and may have received or may receive patents that overlap or conflict with our patents or patent applications, either by claiming the
same product candidates or methods or by claiming subject matter that could dominate our patent position. The patentability of devices
and methods in our technical field may involve complex legal and factual questions, and, therefore, the scope, validity and enforceability
of any patent claims that we may obtain cannot be predicted with certainty.

Though
an issued patent is presumed valid and enforceable, its issuance is not conclusive as to its validity or its enforceability. Patents
may be challenged, deemed unenforceable, invalidated, circumvented, or found not infringed. Proceedings challenging our patents could
result in either the loss or reduction in scope of one or more of the claims of the patent. Furthermore, an adverse decision in an interference
proceeding or a derivation proceeding could result in a third party receiving the patent rights sought by us, which in turn could affect
our ability to commercialize our technologies. Any successful challenge to our patents could deprive us of exclusive rights necessary
for the successful commercialization of our product candidates and methods. In addition, defending such challenges may be costly.

Patents
have a limited lifespan. In the United States, the natural expiration of a utility patent is generally 20 years after its effective filing
date and the natural expiration of a design patent is generally 14 years after its issue date, unless the filing date occurred on or
after May 13, 2015, in which case the natural expiration of a design patent is generally 15 years after its issue date. Further, if we
encounter delays in our development efforts, the period of time during which we could market our product candidates and methods under
patent protection would be reduced and, given the amount of time required for the development, testing and regulatory review of planned
or future product candidates and methods, patents protecting such product candidates and methods might expire before or shortly after
such product candidates and methods are commercialized. As a result, our intellectual property may not provide us with sufficient rights
to exclude others from commercializing product candidates and methods similar or identical to ours.

Furthermore,
patents may not provide us with adequate proprietary protection or competitive advantages against competitors with similar product candidates.
Competitors may be able to design around our patents. Other parties may develop and obtain patent protection for more effective technologies,
designs or methods. The laws of some foreign countries do not protect our proprietary rights to the same extent as the laws of the United
States, and we may encounter significant problems in protecting our proprietary rights in these countries. Competitors may export otherwise
infringing product candidates to territories where we have patent protection but enforcement is not as strong as that in the United States.
These product candidates may compete with our product candidates, and our patents or other intellectual property rights may not be effective
or sufficient to prevent them from competing. If any of these developments were to occur, they each could have a negative impact on our
business and competitive position.

Our
ability to enforce our patent rights depends on our ability to detect infringement. It may be difficult to detect infringers who do not
advertise the use of infringing product candidates, the practice of infringing methods, or the incorporation of infringing components
in their product candidates. It may be difficult or impossible to obtain evidence of infringement in a competitor’s or potential
competitor’s product, or infringing uses or sales by a customer of a competitor. We may not prevail in any lawsuits that we initiate,
and the damages or other remedies awarded if we were to prevail may not be commercially meaningful. In addition, third parties may attempt
to commercialize competitive product candidates or methods in foreign countries where we do not have any patents or patent applications
and/or where legal recourse may be limited. This may have a significant commercial impact on our foreign business operations.